Hj. Vanderwoude et al., OSTEOSARCOMA AND EWINGS-SARCOMA AFTER NEOADJUVANT CHEMOTHERAPY - VALUE OF DYNAMIC MR-IMAGING IN DETECTING VIABLE TUMOR BEFORE SURGERY, American journal of roentgenology, 165(3), 1995, pp. 593-598
OBJECTIVE. This study analyzed the value of dynamic contrast-enhanced
and subtraction MR images in detecting residual viable tumor before su
rgery, with emphasis on timing of enhancement, in patients with high-g
rade osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy.
SUBJECTS AND METHODS, Twenty-one patients with proved osteosarcoma or
Ewing's sarcoma were treated with neoadjuvant chemotherapy followed by
surgery, After IV administration of gadopentetate dimeglumine, dynami
c enhancement patterns on preoperative MR images were compared with co
rresponding areas on histologic sections of the resected specimens. On
dynamic subtraction images obtained with high temporal resolution (1.
5-3 sec), the interval between arrival of the bolus of contrast agent
in an artery and start of tumoral enhancement was used to distinguish
residual viable tumor, Early enhancing foci (interval artery-tumor < 6
sec) and late or nonenhancing areas seen on MR images were correlated
with the histopathologic findings in these areas of the resected spec
imens. RESULTS. Early and progressively enhancing structures seen on M
R images corresponded to feeding arteries, physeal vessels, or residua
l viable tumor at specific preferential sites on corresponding histolo
gic sections of the resected specimens. Tumor foci as small as 3-5 mm(
2) could be detected on dynamic MR images. Remnant viable tumor was of
ten located subperiosteally and at the margins of the tumor, Occasiona
lly, active periosteal reaction without presence of viable tumor contr
ibuted to early enhancement. Late and gradually enhancing or nonenhanc
ing areas corresponded histopathologically to regions of chemotherapy-
induced necrosis, mucomyxoid degeneration, or fibrosis, Alternatively,
late or nonenhancing areas were associated with reactive changes such
as edema, hemorrhage, or osteomyelitis or with tumor-related extracel
lular matrices such as abundant osteoid or chondroid, Viable tumor are
as with scarce formation of matrix on microscopy, such as small cell o
steosarcoma areas or Ewing's sarcoma, showed early enhancement with ra
pid washout of contrast agent on the dynamic MR images. CONCLUSION. Fa
st dynamic contrast-enhanced sequences are essential for identifying r
esidual tumor before surgery, A short time interval of less than 6 sec
between arterial enhancement and tumoral enhancement strongly correla
tes with presence of viable tumor. Both therapy-related alterations of
tissue and tumor-related matrices must be considered when late or lac
k of enhancement is noted on dynamic MR images.